Bain uses cookies to improve functionality and performance of this site. More information can be found in our Privacy Policy. By continuing to browse this site, you consent to the use of cookies.

S&P Global

Bain & Co.'s Rafael Natanek on how to make your drug launch a success

  • September 27, 2017
  • min read

S&P Global

Bain & Co.'s Rafael Natanek on how to make your drug launch a success

Following a survey of 100 executives at the top 20 pharmaceutical companies, Rafael Natanek, a partner with Bain & Company, talked to S&P Global Market Intelligence about the critical importance of a successful new drug launch, given that drug companies will derive 25% to 80% of their revenue from new medicines by 2021.

Go to S&P Global

Subscription required